Statins activate human PPARα promoter and increase PPARα mRNA expression and activation in HepG2 cells

PPAR Research

Volumn , Issue , 2008, Pages

  Seo, Makoto ^a   Inoue, Ikuo ^a   Ikeda, Masaaki ^a   Nakano, Takanari ^a   Takahashi, Seiichiro ^a   Katayama, Shigehiro ^a   Komoda, Tsugikazu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A OXIDASE; ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; HUMAN CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION;

EID: 58149460011     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/316306     Document Type: Article

References (35)

1. Brown M. S., Goldstein J. L., A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood Proceedings of the National Academy of Sciences of the United States of America 1999 96 20 11041 11048
2. Fan P., Zhang B., Kuroki S., Saku K., Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 α -hydroxylase gene expression in HepG2 cells Circulation Journal 2004 68 11 1061 1066
3. Saiki A., Murano T., Watanabe F., Oyama T., Miyashita Y., Shirai K., Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes Journal of Atherosclerosis and Thrombosis 2005 12 3 163 168
4. Tonkin A., Aylward P., Colquhoun D., Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris The American Journal of Cardiology 1995 76 7 474 479
5. Ballantyne C. M., Olsson A. G., Cook T. J., Mercuri M. F., Pedersen T. R., Kjekshus J., Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S Circulation 2001 104 25 3046 3051
6. Streja L., Packard C. J., Shepherd J., Cobbe S., Ford I., Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West of Scotland Coronary Prevention Study (WOSCOPS) The American Journal of Cardiology 2002 90 7 731 736
7. Laufs U., Marra D., Node K., Liao J. K., 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing Rho GTPase-induced down-regulation of p 27 K i p 1 The Journal of Biological Chemistry 1999 274 31 21926 21931
8. Takemoto M., Kitahara M., Yokote K., NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells British Journal of Pharmacology 2001 133 1 83 88
9. Ding Q., Hayashi T., Packiasamy A. J., The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase Life Sciences 2004 75 26 3185 3194
10. Christ M., Bauersachs J., Liebetrau C., Heck M., Günther A., Wehling M., Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation Diabetes 2002 51 8 2648 2652
11. Inoue I., Goto S.-I., Mizotani K., Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of mRNA levels for interleukin-1 β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPAR α) in primary endothelial cells Life Sciences 2000 67 8 863 876
12. Schoonjans K., Staels B., Auwerx J., The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation Biochimica et Biophysica Acta 1996 1302 2 93 109
13. Willson T. M., Brown P. J., Sternbach D. D., Henke B. R., The PPARs: from orphan receptors to drug discovery Journal of Medicinal Chemistry 2000 43 4 527 550
14. Gearing K. L., Gottlicher M., Teboul M., Widmark E., Gustafsson J. A., Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor Proceedings of the National Academy of Sciences of the United States of America 1993 90 4 1440 1444
15. Mandard S., Müller M., Kersten S., Peroxisome proliferator-activated receptor α target genes Cellular and Molecular Life Sciences 2004 61 4 393 416
16. Kersten S., Peroxisome proliferator activated receptors and lipoprotein metabolism PPAR Research 2008 2008 11
17. Aoki T., Yoshinaka Y., Yamazaki H., Triglyceride-lowering effect of pitvastatin in a rat model of postprandial lipemia European Journal of Pharmacology 2002 444 1-2 107 113
18. Nicholls S. J., Tuzcu E. M., Sipahi I., Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study) The American Journal of Cardiology 2006 97 11 1553 1557
19. Kostapanos M. S., Milionis H. J., Lagos K. G., Rizos C. B., Tselepis A. D., Elisaf M. S., Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia European Journal of Pharmacology 2008 590 1-3 327 332
20. Planavila A., Laguna J. C., Vazquez-Carrera M., Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor- κ B activation Biochimica et Biophysica Acta 2005 1687 1-3 76 83
21. Zapolska-Downar D., Siennicka A., Kaczmarczyk M., Kołodziej B., Naruszewicz M., Simvastatin modulates TNF α -induced adhesion molecules expression in human endothelial cells Life Sciences 2004 75 11 1287 1302
22. Landrier J.-F., Thomas C., Grober J., Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator- activated receptor- α -dependent The Journal of Biological Chemistry 2004 279 44 45512 45518
23. Torra I. P., Jamshidi Y., Flavell D. M., Fruchart J.-C., Staels B., Characterization of the human PPAR α promoter: identification of a functional nuclear receptor response element Molecular Endocrinology 2002 16 5 1013 1028
24. Inoue I., Hayashi K., Yagasaki F., Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor γ 1 (PPAR γ 1) and PPAR α genes Journal of Atherosclerosis and Thrombosis 2003 10 2 99 108
25. Inoue I., Shinoda Y., Ikeda M., CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response element Journal of Atherosclerosis and Thrombosis 2005 12 3 169 174
26. Lundbye J. B., Thompson P. D., Statin use in the metabolic syndrome Current Atherosclerosis Reports 2005 7 1 17 21
27. Palinski W., New evidence for beneficial effects of statins unrelated to lipid lowering Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 1 3 5
28. Kleemann R., Princen H. M. G., Emeis J. J., Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE * 3 -Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin Circulation 2003 108 11 1368 1374
29. Grip O., Janciauskiene S., Lindgren S., Atorvastatin activates PPAR- γ and attenuates the inflammatory response in human monocytes Inflammation Research 2002 51 2 58 62
30. Gottlicher M., Widmark E., Li Q., Gustafsson J. A., Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4653 4657
31. Lake B. G., Mechanisms of hepatocarcinogenicity of peroxisome- proliferating drugs and chemicals Annual Review of Pharmacology and Toxicology 1995 35 483 507
32. Dowell P., Ishmael J. E., Avram D., Peterson V. J., Nevrivy D. J., Leid M., p300 functions as a coactivator for the peroxisome proliferator-activated receptor α The Journal of Biological Chemistry 1997 272 52 33435 33443
33. Zhu Y., Qi C., Jain S., Rao M. S., Reddy J. K., Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor The Journal of Biological Chemistry 1997 272 41 25500 25506
34. Puigserver P., Wu Z., Park C. W., Graves R., Wright M., Spiegelman B. M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 1998 92 6 829 839
35. Glass C. K., Going nuclear in metabolic and cardiovascular disease Journal of Clinical Investigation 2006 116 3 556 560